抑制RIPK3/MLKL介导的牙龈成纤维细胞坏死性凋亡可减轻牙周炎
该研究通过再分析GEO数据集GSE164241并结合健康者与牙周炎患者牙龈标本,发现牙周炎牙龈中成纤维细胞的坏死性凋亡评分最高。在结扎诱导的小鼠牙周炎模型中,局部给予RIPK3抑制剂GSK'872或sh-Mlkl可显著抑制坏死性凋亡并改善牙周炎;体外实验显示坏死性凋亡抑制剂减轻LPS或LAZ诱导的牙龈成纤维细胞炎症反应及损伤相关分子模式释放,进而减少THP-1细胞迁移与M1极化。结论提示牙龈成纤维细胞坏死性凋亡加重牙龈炎症和牙槽骨丢失,抑制该过程可能成为牙周炎治疗靶点。
要点
- 牙周炎牙龈成纤维细胞中坏死性凋亡相关蛋白升高。
- 局部抑制RIPK3或MLKL可减轻小鼠牙周炎。
- 坏死性凋亡抑制剂减少THP-1迁移与M1极化。
核心结论
- 牙龈成纤维细胞坏死性凋亡加重牙龈炎症和牙槽骨丢失。
- 坏死性凋亡抑制剂通过调节THP-1巨噬细胞迁移和极化减轻牙周炎。
研究设计与样本
- 再分析GEO数据集GSE164241以识别坏死性凋亡在牙周炎中的作用。
- 收集健康者与牙周炎患者牙龈标本评估坏死性凋亡相关蛋白表达。
- 在体内和体外评估坏死性凋亡抑制剂对牙周炎的治疗效果。
- 采用Transwell实验、Western blotting和siRNA转染鉴定坏死性凋亡的牙龈成纤维细胞对THP-1巨噬细胞的影响。
主要发现
- 再分析显示牙周炎牙龈中牙龈成纤维细胞的坏死性凋亡曲线下面积评分最高。
- 患者和小鼠牙周炎牙龈成纤维细胞中坏死性凋亡相关蛋白水平升高。
- 结扎诱导牙周炎小鼠局部给予RIPK3抑制剂GSK'872或sh-Mlkl可显著抑制坏死性凋亡并改善牙周炎。
- 坏死性凋亡抑制剂减轻LPS或LAZ诱导的牙龈成纤维细胞炎症反应及损伤相关分子模式释放。
- 坏死性凋亡抑制剂减少THP-1细胞迁移和M1极化。
临床怎么用
- RIPK3/MLKL介导的坏死性凋亡可能作为牙周炎潜在治疗靶点。
- 调节巨噬细胞迁移与M1极化可能是坏死性凋亡抑制剂发挥作用的途径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Necroptosis participates in the pathogenesis of many inflammatory diseases, including periodontitis. Here, we aimed to investigate the role and mechanism of necroptosis inhibitors in attenuating periodontitis. MATERIALS AND METHODS: The Gene Expression Omnibus (GEO) dataset GSE164241 was re-analysed to identify the role of necroptosis in periodontitis. Gingival specimens from healthy subjects or periodontitis patients were collected to evaluate the expression level of necroptosis-associated proteins. The therapeutic effect of necroptosis inhibitors on periodontitis was assessed in vivo and in vitro. Moreover, Transwell assays and Western blotting and siRNA transfection were used to identify the effects of necroptotic human gingival fibroblasts (hGFs) on THP-1 macrophages. RESULTS: Re-analysis revealed that gingival fibroblasts (GFs) in periodontitis gingiva showed the highest area under the curve score of necroptosis. Elevated levels of necroptosis-associated proteins were identified in GFs in periodontitis gingiva collected from patients and mice. In ligature-induced periodontitis mice, local administration of receptor interacting protein kinase 3(RIPK3) inhibitor GSK'872 or sh-mixed-lineage kinase domain-like pseudokinase (Mlkl) markedly abrogated necroptosis and rescued periodontitis. Analogously, necroptosis inhibitors alleviated the inflammatory response and release of damage-associated molecular patterns in lipopolysaccharide- or LAZ (LPS + AZD'5582 + z-VAD-fmk, necroptosis inducer)-induced GFs and then reduced THP-1 cell migration and M1 polarization. CONCLUSIONS: Necroptosis in GFs aggravated gingival inflammation and alveolar bone loss. Necroptosis inhibitors attenuate this process by modulating THP-1 macrophage migration and polarization. This study offers novel insights into the pathogenesis and potential therapeutic targets of periodontitis.
引用
- Zhang K, Chen X, Zhou R, et al. Inhibition of gingival fibroblast necroptosis mediated by RIPK3/MLKL attenuates periodontitis. J Clin Periodontol. 2023. PMID: 37366309. doi:10.1111/jcpe.13841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。